[go: up one dir, main page]

FR2863269B1 - SPECIFIC PEPTIDES FOR THE DIAGNOSIS OF HEART FAILURE - Google Patents

SPECIFIC PEPTIDES FOR THE DIAGNOSIS OF HEART FAILURE

Info

Publication number
FR2863269B1
FR2863269B1 FR0500425A FR0500425A FR2863269B1 FR 2863269 B1 FR2863269 B1 FR 2863269B1 FR 0500425 A FR0500425 A FR 0500425A FR 0500425 A FR0500425 A FR 0500425A FR 2863269 B1 FR2863269 B1 FR 2863269B1
Authority
FR
France
Prior art keywords
diagnosis
heart failure
specific peptides
peptides
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0500425A
Other languages
French (fr)
Other versions
FR2863269A1 (en
Inventor
Bernard Pau
Isabelle Karine Giuliani
Francois Yves Rieunier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Montpellier
Bio Rad Innovations SAS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite de Montpellier
Bio Rad Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite de Montpellier, Bio Rad Pasteur SA filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0500425A priority Critical patent/FR2863269B1/en
Publication of FR2863269A1 publication Critical patent/FR2863269A1/en
Application granted granted Critical
Publication of FR2863269B1 publication Critical patent/FR2863269B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
FR0500425A 2005-01-14 2005-01-14 SPECIFIC PEPTIDES FOR THE DIAGNOSIS OF HEART FAILURE Expired - Fee Related FR2863269B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0500425A FR2863269B1 (en) 2005-01-14 2005-01-14 SPECIFIC PEPTIDES FOR THE DIAGNOSIS OF HEART FAILURE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0500425A FR2863269B1 (en) 2005-01-14 2005-01-14 SPECIFIC PEPTIDES FOR THE DIAGNOSIS OF HEART FAILURE

Publications (2)

Publication Number Publication Date
FR2863269A1 FR2863269A1 (en) 2005-06-10
FR2863269B1 true FR2863269B1 (en) 2006-05-26

Family

ID=34586508

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0500425A Expired - Fee Related FR2863269B1 (en) 2005-01-14 2005-01-14 SPECIFIC PEPTIDES FOR THE DIAGNOSIS OF HEART FAILURE

Country Status (1)

Country Link
FR (1) FR2863269B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA971864B (en) * 1996-03-04 1997-12-18 Scios Inc Assays and reagents for quantifying hBNP.
US6117644A (en) * 1998-06-04 2000-09-12 Ottawa Heart Institute Research Corporation Predicting and detecting cardiac allograft rejection
GB9827348D0 (en) * 1998-12-12 1999-02-03 Univ Leicester Natriuretic peptide
CN1327228C (en) * 1999-01-29 2007-07-18 罗赫诊断器材股份有限公司 Method for identifying N-terminal proBNP in a sample

Also Published As

Publication number Publication date
FR2863269A1 (en) 2005-06-10

Similar Documents

Publication Publication Date Title
EP1976558A4 (en) USE OF AN IMMUNOGENIC COMPOSITION OF PCV2 FOR THE REDUCTION OF CLINICAL SYMPTOMS
DE602006010476D1 (en) Implantable cardiac diagnostic system
EP1983926A4 (en) ENDOSCOPE COMPRISING IMAGING CAPSULE
FR2919305B1 (en) ADENO-ASSOCIATED VIRAL VECTORS FOR THE EXPRESSION OF DYSFERLINE.
EP1951355A4 (en) MEDICAL FLUID INJECTION SYSTEM
EP1865976A4 (en) USE OF NATRIURETIC PEPTIDE FOR THE TREATMENT OF CARDIAC INSUFFICIENCY
EP1913388A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND MONITORING OF ATHEROSCLEROUS CARDIOVASCULAR DISEASE
EP1855581A4 (en) CAPTIVE CAPSULE TYPE ENDOSCOPE FOR THE EXPLORATION OF BARRETT'S ESOPHAGUS
DE602005015418D1 (en) MONITORING SYSTEM FOR THE HUMAN BODY
EP2217311A4 (en) PATIENT INTERFACE ASSEMBLY FOR RESPIRATORY THERAPY
EP2216651A4 (en) BIOMARKER FOR THE DIAGNOSIS OF A HEPATIC DISEASE
WO2003006491A3 (en) Peptide-based compounds for targeting intergin receptors
EP2280637A4 (en) NON-INVASIVE PHYSIOLOGICAL SENSOR PLACED OUTSIDE THE EAR
EP2473636A4 (en) INTERFERON DIAGNOSIS TYPE 1
EP1941908A4 (en) THERAPEUTIC AGENT FOR HEART DISEASE
EP1937150A4 (en) Probe for ultrasound diagnosis and ultrasound diagnostic system using the same
EP2198292A4 (en) BETTER DIAGNOSIS OF ALZHEIMER'S DISEASE
EP1797903A4 (en) DIAGNOSTIC AGENT FOR TUMOR
EP1815872A4 (en) COMPOSITION FOR THE DIAGNOSIS OF DISEASES ASSOCIATED WITH AMYLOIDS
EP1758605A4 (en) PROUROGUANYLINE AS THERAPEUTIC OR DIAGNOSTIC AGENTS
ITTO20060614A1 (en) "DIFFERENTIAL DIAGNOSIS FOR THE SCLERODERMIA"
WO2008026040A3 (en) 68ga-labeled peptide-based radiopharmaceuticals
FR2949472B1 (en) PROTEINS USED FOR THE DIAGNOSIS OF A LYME BORRELIOSE
DE602006004232D1 (en) Device for imaging the ocular fundus
EP2080526A4 (en) RADIOACTIVE DIAGNOSTIC IMAGING AGENT

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091130

RN Application for restoration
D3 Decision to revoke the decision of lapse
CD Change of name or company name
CJ Change in legal form
PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

ST Notification of lapse

Effective date: 20210405